EOJOAM
CVS icon

E. Ohman J:or Asset Management’s CVS Health CVS Stock Holding History

E. Ohman J:or Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Sell
30,455
-13,150
-30% -$1.17M 0.07% 139
2026
Q1 		$3.13M Sell
43,605
-1,300
-3% -$100K 0.08% 129
2025
Q4 		$3.56M Sell
44,905
-7,540
-14% -$594K 0.08% 114
2025
Q3 		$3.95M Hold
52,445
– – 0.09% 107
2025
Q2 		$3.62M Sell
52,445
-2,505
-5% -$164K 0.09% 107
2025
Q1 		$3.72M Sell
54,950
-2,400
-4% -$144K 0.1% 108
2024
Q4 		$2.57M Buy
57,350
+7,070
+14% +$397K 0.06% 138
2024
Q3 		$3.16M Sell
50,280
-4,820
-9% -$281K 0.08% 113
2024
Q2 		$3.25M Buy
55,100
+2,200
+4% +$138K 0.08% 114
2024
Q1 		$4.22M Buy
52,900
+1,500
+3% +$115K 0.11% 100
2023
Q4 		$4.06M Sell
51,400
-6,300
-11% -$448K 0.15% 84
2023
Q3 		$4.03M Sell
57,700
-1,700
-3% -$120K 0.15% 86
2023
Q2 		$4.11M Hold
59,400
– – 0.15% 92
2023
Q1 		$4.41M Buy
59,400
+4,000
+7% +$335K 0.17% 86
2022
Q4 		$5.16M Sell
55,400
-2,300
-4% -$222K 0.23% 73
2022
Q3 		$5.5M Buy
+57,700
New +$5.71M 0.25% 67
2022
Q2 		– Sell
-60,525
Closed -$6.13M – 429
2022
Q1 		$6.13M Sell
60,525
-3,200
-5% -$336K 0.21% 76
2021
Q4 		$6.57M Buy
63,725
+4,100
+7% +$379K 0.19% 80
2021
Q3 		$5.06M Buy
59,625
+600
+1% +$50.3K 0.16% 92
2021
Q2 		$4.93M Buy
59,025
+7,000
+13% +$573K 0.15% 93
2021
Q1 		$3.91M Sell
52,025
-5,600
-10% -$408K 0.14% 94
2020
Q4 		$3.94M Buy
57,625
+4,300
+8% +$280K 0.16% 90
2020
Q3 		$3.11M Buy
53,325
+5,100
+11% +$317K 0.15% 85
2020
Q2 		$3.13M Buy
48,225
+2,200
+5% +$139K 0.18% 81
2020
Q1 		$2.73M Sell
46,025
-18,800
-29% -$1.26M 0.2% 67
2019
Q4 		$4.82M Buy
64,825
+6,525
+11% +$458K 0.27% 60
2019
Q3 		$3.68M Buy
58,300
+3,200
+6% +$190K 0.23% 64
2019
Q2 		$3M Buy
55,100
+4,100
+8% +$221K 0.2% 70
2019
Q1 		$2.75M Hold
51,000
– – 0.19% 76
2018
Q4 		$3.34M Buy
51,000
+1,600
+3% +$119K 0.24% 70
2018
Q3 		$3.89M Buy
49,400
+5,400
+12% +$386K 0.25% 76
2018
Q2 		$2.83M Buy
44,000
+13,900
+46% +$916K 0.2% 84
2018
Q1 		$1.87M Buy
30,100
+6,000
+25% +$430K 0.15% 96
2017
Q4 		$1.75M Sell
24,100
-3,100
-11% -$225K 0.14% 100
2017
Q3 		$2.21M Buy
27,200
+400
+1% +$31.6K 0.2% 81
2017
Q2 		$2.16M Sell
26,800
-1,400
-5% -$111K 0.22% 77
2017
Q1 		$2.21M Buy
28,200
+3,600
+15% +$287K 0.27% 75
2016
Q4 		$1.94M Buy
24,600
+2,100
+9% +$170K 0.27% 76
2016
Q3 		$2M Buy
22,500
+1,200
+6% +$113K 0.3% 70
2016
Q2 		$2.04M Buy
21,300
+1,000
+5% +$99.7K 0.34% 68
2016
Q1 		$2.11M Sell
20,300
-1,400
-6% -$136K 0.38% 59
2015
Q4 		$2.12M Hold
21,700
– – 0.37% 64
2015
Q3 		$2.09M Sell
21,700
-1,100
-5% -$116K 0.56% 43
2015
Q2 		$2.39M Sell
22,800
-1,100
-5% -$112K 0.56% 43
2015
Q1 		$2.47M Sell
23,900
-1,400
-6% -$142K 0.57% 42
2014
Q4 		$2.47M Sell
25,300
-1,300
-5% -$115K 0.59% 39
2014
Q3 		$2.12M Hold
26,600
– – 0.52% 40
2014
Q2 		$2M Hold
26,600
– – 0.49% 42
2014
Q1 		$1.99M Sell
26,600
-4,500
-14% -$318K 0.49% 40
2013
Q4 		$2.23M Sell
31,100
-300
-1% -$19.3K 0.52% 38
2013
Q3 		$1.78M Buy
31,400
+1,800
+6% +$107K 0.45% 47
2013
Q2 		$1.69M Buy
+29,600
New +$1.71M 0.47% 42

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

E. Ohman J:or Asset Management's CVS Position: Q2 2026 in Review

E. Ohman J:or Asset Management reduced its CVS Health (CVS) stake by 30% in Q2 2026, selling an estimated $1.17M and leaving 30,455 shares worth $3.15M. The position accounts for 0.07% of the portfolio, ranked #139.

E. Ohman J:or Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.57M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • E. Ohman J:or Asset Management held 30,455 shares of CVS Health worth $3.15M as of Q2 2026.
  • E. Ohman J:or Asset Management sold 13,150 CVS Health shares in Q2 2026, an estimated $1.17M.
  • CVS Health made up 0.07% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #139 holding.
  • E. Ohman J:or Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • E. Ohman J:or Asset Management's CVS Health position peaked at $6.57M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.